BlackBerry, NantHealth launch NantOmics Cancer Genome Browser

Blackberry and NantHealth, cloud based information technology provider announced the first secure clinical genome browser that gives doctors unprecedented access to patients’ genetic data on the BlackBerry passport smartphone- The NantOmics Cancer Genome Browser.

The NantOmicsCancer Genome Browser platform on the BlackBerry Passport enables deep, interactive reporting on genomics data for physicians and other treatment providers in clinical settings – for example, giving oncologists a powerful view into the individual genetic alternations that make each patient’s disease unique and highlighting relevant treatment options. The BlackBerry Passport’s large high resolution screen enables clinicians to view a patient’s chromosome at an individual base-pair level. It is the first in a series of innovative offerings being developed jointly by BlackBerry and NantHealth for use by healthcare professionals.

“BlackBerry’s partnership with NantHealth illustrates how the mobile security and collaboration technology we are known for can be re-imagined to create applications across a variety of industries,” said John Chen, Executive Chairman and CEO, BlackBerry. “BlackBerry technology has proven itself secure, reliable and powerful enough to be counted on in life-and-death situations. Its innovative form and functionality make BlackBerry Passport an ideal addition to adoctor’s medical kit.”

Powered by BlackBerry’s mobile security infrastructure, the NantOmics Cancer Genome Browser is fully encrypted to allow deployment in a HIPAA-secured environment, enabling clinicians to securely access patient data as soon as it’s available, wherever they are. BlackBerry’s recently launched BES12 cross-platform EMM solution will enable hospital IT administrators to easily deploy the application to aclinician’s BlackBerry Passport smartphone and ensures that the application data is fully secure end-to-end.